PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
07-Nov-2022 Oxular Limited Appoints Industry Veteran James Jogerst as Chief Business Officer Businesswire
07-Nov-2022 LevitasBio Completes Series C Financing Businesswire
07-Nov-2022 Global Crohn's Disease Therapeutics Market to 2027 - Adoption of Biologic Therapies is Driving Growth - ResearchAndMarkets.com Businesswire
07-Nov-2022 Global RNA Analysis Market Report 2022: Single Cell Transcriptomics And Associated Big Data Presents Opportunities - ResearchAndMarkets.com Businesswire
07-Nov-2022 Rallybio Announces Positive Phase 1 Single Ascending Dose Results for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5 Businesswire
07-Nov-2022 ADC Therapeutics to Participate in the Jefferies London Healthcare Conference Businesswire
07-Nov-2022 Global Primary Cells Market Report 2022: Growing Demand for HLA-Typed Human Primary Cells Presents Opportunities - ResearchAndMarkets.com Businesswire
07-Nov-2022 bluebird bio Reports Third Quarter 2022 Financial Results and Highlights Operational Progress Businesswire
07-Nov-2022 Glaukos Announces Participation in the Stephens Annual Investment Conference Businesswire
07-Nov-2022 The Worldwide Cold Pain Therapy Industry is Expected to Reach $2.4 Billion by 2027 at a 5.1% CAGR - ResearchAndMarkets.com Businesswire
07-Nov-2022 Reductions in Certain Types of HPV-Related Cervical and Non-Cervical Diseases in Women and Men Observed with Real-World Use of Merck's GARDASIL® in Systematic Literature Review of 138 Studies Businesswire
07-Nov-2022 KalVista Pharmaceuticals to Present at Upcoming Investor Conferences Businesswire
07-Nov-2022 Calysta and Adisseo Developing Plan to Bring Major Alternative Protein Facility to Kingdom of Saudi Arabia Businesswire
07-Nov-2022 eClinical Solutions Global Market Report 2022: Accelerated Decision Making Capacity Driving Adoption - ResearchAndMarkets.com Businesswire
07-Nov-2022 Global Enteral Feeding Formulas Market Report 2022: Ease of Use and Low Costs Driving Adoption - ResearchAndMarkets.com Businesswire
07-Nov-2022 Cerveau Technologies Inc. and LEXEO Therapeutics, Inc.- Sign Agreement to Provide Novel Tau Imaging Biomarker for Disease Modifier Research Businesswire
07-Nov-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
07-Nov-2022 Transgene Reports Business Update And Q3 2022 Financial Position Businesswire
07-Nov-2022 Sensorion Announces US FDA Grants Rare Pediatric Disease Designation to OTOF-GT for the Treatment of Otoferlin Gene-Mediated Hearing Loss Businesswire
07-Nov-2022 Genomic Vision and Cambridge Consultants, Part of Capgemini, Announce the Development of an Innovative Technology Platform for In-depth Genomic Analysis Businesswire